Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of oral solid forms for the pharmaceutical and nutraceutical industries. It offers pharmaceutical products, including powders and granules, capsules, tablets, film-coated tablets, effervescent granules, and hard gelatine capsules. The company also provides nutraceutical products comprising soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, fast melting/sublingual tablets, film-coated tablets, and hard gelatin capsules for various therapeutic areas, such as probiotics, multivitamins and minerals, immune systems, sleep and relax, gastrointestinal system, circulatory system, osteoarticular system, urinary system, women health, beauty, healthy ageing, and mental wellbeing. In addition, the company manufactures and trades in cosmetics products consisting of hair care, skin care, liquid detergents for personal hygiene, skin care emulsions, oral hygiene, deodorants, alcohol-based perfumery, bath and shower gel, shampoo and conditioners, shaping waxes, mouthwash and breath products, creams, gel and toothpaste, roll-on, stick and vapo spray deodrants, intimate cleansers, emulsions and microemulsions, gels, and liquid soaps; medical surgical aids and medical devices; antiseptics for undamaged skin, hand gel, pre-injection, hydroalcoholic surfaces, and iodine; and orthodontic cleaning tablets, disinfectants, and decongestant nasal sprays. The company was founded in 1984 and is headquartered in Verdellino, Italy.
Fine Foods & Pharmaceuticals Dividend Announcement
• Fine Foods & Pharmaceuticals announced a annually dividend of €0.12 per ordinary share which will be made payable on 2024-06-05. Ex dividend date: 2024-06-03
• Fine Foods & Pharmaceuticals annual dividend for 2024 was €0.12
• Fine Foods & Pharmaceuticals annual dividend for 2023 was €0.10
• Fine Foods & Pharmaceuticals's trailing twelve-month (TTM) dividend yield is 1.46%
• Fine Foods & Pharmaceuticals's payout ratio for the trailing twelve months (TTM) is 112.54%
Fine Foods & Pharmaceuticals Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-03 | €0.12 | annually | 2024-06-05 |
2023-05-22 | €0.10 | annually | 2023-05-24 |
2022-05-23 | €0.16 | annually | 2022-05-25 |
2021-05-03 | €0.14 | annually | 2021-05-05 |
2020-05-11 | €0.12 | annually | 2020-05-13 |
2019-05-03 | €0.10 | annually | 2019-05-08 |
Fine Foods & Pharmaceuticals Dividend per year
Fine Foods & Pharmaceuticals Dividend growth
Fine Foods & Pharmaceuticals Dividend Yield
Fine Foods & Pharmaceuticals current trailing twelve-month (TTM) dividend yield is 1.46%. Interested in purchasing Fine Foods & Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
Fine Foods & Pharmaceuticals Financial Ratios
Fine Foods & Pharmaceuticals Dividend FAQ
Other factors to consider when evaluating Fine Foods & Pharmaceuticals as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Fine Foods & Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Fine Foods & Pharmaceuticals's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Fine Foods & Pharmaceuticals publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Fine Foods & Pharmaceuticals distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Fine Foods & Pharmaceuticals are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Fine Foods & Pharmaceuticals sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Fine Foods & Pharmaceuticals distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Fine Foods & Pharmaceuticals declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Fine Foods & Pharmaceuticals's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Fine Foods & Pharmaceuticals's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.